CWM
AGN

Calamos Wealth Management’s Allergan plc AGN Stock Holding History

Calamos Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-32,447
Closed -$5.46M – 223
2018
Q1 		$5.46M Buy
32,447
+9,498
+41% +$1.59M 0.68% 53
2017
Q4 		$3.75M Sell
22,949
-3,304
-13% -$593K 0.49% 66
2017
Q3 		$5.38M Buy
26,253
+20,415
+350% +$4.75M 0.75% 42
2017
Q2 		$1.42M Buy
5,838
+37
+0.6% +$8.69K 0.2% 117
2017
Q1 		$1.39M Sell
5,801
-1,236
-18% -$288K 0.21% 117
2016
Q4 		$1.48M Sell
7,037
-755
-10% -$156K 0.24% 123
2016
Q3 		$1.79M Sell
7,792
-787
-9% -$192K 0.31% 107
2016
Q2 		$1.98M Buy
+8,579
New +$1.98M 0.35% 90

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Calamos Wealth Management's AGN Position: Q2 2018 in Review

Calamos Wealth Management sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 32,447 shares — an estimated $5.46M sold.

Calamos Wealth Management first reported a position in AGN in Q2 2016 and held it in 8 quarters. The position peaked at $5.46M in Q1 2018. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Calamos Wealth Management reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Calamos Wealth Management sold 32,447 Allergan plc shares in Q2 2018, an estimated $5.46M.
  • Calamos Wealth Management first reported a position in Allergan plc in Q2 2016 and held it in 8 quarters.
  • Calamos Wealth Management's Allergan plc position peaked at $5.46M in Q1 2018.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Calamos Wealth Management's 13F filing for Q2 2018, filed 17 Jul 2018.